Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Vigo (35)

2024

  1. A comprehensive, predictive mortality score for patients with bloodstream infections (PROBAC): a prospective, multicentre cohort study

    Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 8, pp. 1794-1800

  2. Association of microbiological factors with mortality in Escherichia coli bacteraemia presenting with sepsis/septic shock: a prospective cohort study

    Clinical Microbiology and Infection, Vol. 30, Núm. 8, pp. 1035-1041

  3. Differences in clinical outcomes of bloodstream infections caused by Klebsiella aerogenes, Klebsiella pneumoniae and Enterobacter cloacae: a multicentre cohort study

    Annals of Clinical Microbiology and Antimicrobials, Vol. 23, Núm. 1

  4. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

    The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385

  5. Whole-genome characterisation of Escherichia coli isolates from patients with bacteraemia presenting with sepsis or septic shock in Spain: a multicentre cross-sectional study

    The Lancet Microbe, Vol. 5, Núm. 4, pp. e390-e399

2023

  1. A Confounder in the Study of a Patient With Infective Endocarditis

    JACC: Case Reports, Vol. 28

  2. Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales

    Annals of Clinical Microbiology and Antimicrobials, Vol. 22, Núm. 1

  3. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525

  4. Mycotic Aortic Aneurysm after Intravesical Bacillus Calmette-Guérin Instillation for Bladder Carcinoma

    Infectious Diseases in Clinical Practice

2022

  1. Ceftazidime–avibactam treatment in bacteremia caused by OXA-48 carbapenemase-producing Klebsiella pneumoniae

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 41, Núm. 9, pp. 1173-1182

  2. Gastrointestinal colonization by OXA-48-producing Enterobacterales: risk factors for persistent carriage

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 41, Núm. 12, pp. 1399-1405

  3. Oral sequential therapy in the treatment of post-surgical epidural abscess and subdural empyema

    Infection, Vol. 50, Núm. 5, pp. 1385-1389

  4. Risk of cardiac device-related infection in patients with late-onset bloodstream infection. Analysis on a National Cohort

    Journal of Infection, Vol. 85, Núm. 2, pp. 123-129

  5. Successful ceftazidime–avibactam therapy in a patient with multidrug-resistant Pseudomonas aeruginosa infective endocarditis

    Infection

2021

  1. COVID-19 pneumonia in Galicia (Spain): Impact of prognostic factors and therapies on mortality and need for mechanical ventilation

    PLoS ONE, Vol. 16, Núm. 6 June

  2. Clinical characteristics, aetiology and mortality/recurrence risk factors of acute cholangitis in patients with and without biliary stent

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 9, pp. 445-450

  3. Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis

    Clinical Microbiology and Infection

  4. Mortality-related factors in patients with OXA-48 carbapenemase-producing Klebsiella pneumoniae bacteremia

    Medicine, Vol. 100, Núm. 14, pp. e24880

  5. The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia

    International Journal of Infectious Diseases, Vol. 102, pp. 554-560

2020

  1. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1